Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD9604 was specifically designed to include amino acid residues 177191 of hGH with an additional tyrosine residue at the N-terminus
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Advanced Protocol (Weeks 3-12) For individuals with higher body weight, metabolic resistance, or those seeking maximum metabolic enhancement, an advanced 5-amino-1MQ dosage protocol of 100mg daily may be appropriate
Stacking strategically can make results more noticeable and sustainable
By changing how fat cells store and release energy, 5-Amino-1MQ may help make these areas more responsive
Preparation: We recommend you arrive well-hydrated and have a light meal 12 hours before your appointment
